The Turkevich–Frens synthesis starting conditions are expanded, ranging the gold salt concentrations up to 2 mM and citrate/gold(III) molar ratios up to 18:1. For each concentration of the initial gold salt solution, the citrate/gold(III) molar ratios are systematically varied from 2:1 to 18:1 and both the size and size distribution of the resulting gold nanoparticles are compared. This study reveals a different nanoparticle size evolution for gold salt solutions ranging below 0.8 mM compared to the case of gold salt solutions above 0.8 mM. In the case of [Au3+] < 0.8 mM, both the size and size distribution vary substantially with the citrate/gold(III) ratio, both displaying plateaux that evolve inversely to [Au3+] at larger ratios. Conversely, for [Au3+] ≥ 0.8 mM, the size and size distribution of the synthesized gold nanoparticles continuously rise as the citrate/gold(III) ratio is increased. A starting gold salt concentration of 0.6 mM leads to the formation of the most monodisperse gold nanoparticles (polydispersity index < 0.1) for a wide range of citrate/gold(III) molar ratios (from 4:1 to 18:1). Via a model for the formation of gold nanoparticles by the citrate method, the experimental trends in size could be qualitatively predicted: the simulations showed that the destabilizing effect of increased electrolyte concentration at high initial [Au3+] is compensated by a slight increase in zeta potential of gold nanoparticles to produce concentrated dispersion of gold nanoparticles of small sizes.
The assembly of inorganic nanoparticles often leads to collective properties that are different from the combined properties of the individual components. In particular, coupling plasmonic and excitonic nanoparticles has been shown to modify their optical properties, including absorption, emission, and scattering. Because of this, these coupled assemblies have potential applications in a wide range of areas, including sensing, light harvesting, and photocatalysis. More recently, unique properties, including Fano interference and Rabi splitting, have been observed by increasing the coupling strength. However, the behavior of coupled nanoparticles is highly dependent on the exact organization of the components, including the number of particles coupled, the distance separating them, and their spatial orientation. This is especially true in the case of strongly coupled particles. Because of this, it is important to achieve synthetic techniques that not only can link particles together but also offer good control over how the particles are connected. In this review, assemblies of plasmonic and excitonic nanoparticles are reviewed, including the various methods that have been used for their construction, the properties that these systems have been predicted to possess as well as the ones that have been observed, and their current applications along with current challenges in the field and potential future applications.
Cysteamine has a concentration-dependent dual-role of ligand and etchant which leads to controlled etching/tapering of gold nanorods with silica coating.
Dendronized nanoparticles, also called nanoparticle-cored dendrimers, combine the advantages of nanoparticles and dendrimers. These very stable and polyvalent nanoparticles can be used for diverse applications. One such application is drug delivery, because the dendrons can enhance the density of the payload. In this report, we describe the design of multifunctional gold nanoparticles (AuNPs) coated with poly(propylene imine) (PPI) dendrons that contain both prostate cancer active targeting and chemotherapeutic drugs. The PPI dendron is a good candidate for the design of drug delivery vehicles because of its ability to induce a proton sponge effect that will enhance lysosomal escape and intracellular therapeutic delivery. The chemotherapeutic drug used is doxorubicin (DOX), and it was linked to the dendron through a hydrazone acid-sensitive bond. Subsequent acidification of the AuNP system to a pH of 4–5 resulted in the release of 140 DOX drugs per nanoparticles. In addition, the PPI dendron was conjugated via “click” chemistry to an EphA2-targeting antibody fragment that has been shown to target prostate cancer cells. In vitro cell viability assays revealed an IC50 of 0.9 nM for the targeted DOX-bearing AuNPs after 48 h incubation with PC3 cells. These results are very promising upon optimization of the system.